ADVB Advanced Biomed Inc: Bozor kapitallashuvining balans qiymatiga nisbati

advanbiomed.com (ADVB) - korporativ logo

Advanced Biomed Inc (ADVB) qon orqali onkologiyani erta aniqlash uchun mo‘ljallangan noyob chiplar patentlariga tayanadi, bu esa an'anaviy uskunalar qarshisida texnologik to‘siqni yaratadi. Ichki ishlanmalar sikllari biznesning inqirozlarga chidamliligini ta'minlaydi, bunda ko‘rsatkich 11.79 darajasida turibdi. Bozor narxining harakati aktivning joriy dinamikasini aniq namoyish etadi. Biroq, geosiyosiy beqarorlik va sanksiyalar biomateriallar logistikasidagi uzilishlar tufayli yangi dori vositalarini joriy qilishni kechiktirishi mumkin.

Advanced Biomed (ADVB) - Bozor kapitallashuvining balans qiymatiga nisbati 07.03.2025dan 27.10.2026gacha

ADVB (Advanced Biomed Inc): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar

- narx va narxlar bo'yicha konsensus prognoz:
Aksiya narxi advanbiomed.com|ADVB - Maqsadli narxlar grafigi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor kapitallashuvi Advanced Biomed Corp|ADVB - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga balans qiymati Advanced Biomed|ADVB - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati advanbiomed.com|ADVB - Biznesning umumiy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Advanced Biomed Inc|ADVB - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati advanbiomed.com|ADVB - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Advanced Biomed Corp
Fundamental baholash:ADVB (Advanced Biomed Inc.)
Advanced Biomed Inc tayyor mahsulotlari

Ushbu koeffitsiyent aktivning bozor qiymati orqali bir dollarli kapitalning tannarxini belgilaydi. Ushbu metrikaning oshishi kengayish kutimlari haqida signal beradi, biroq haddan tashqari ko'p to'lov qilish xavfi haqida ogohlantiradi. Jori bozor qiymatining balans qiymatiga nisbatini tahlil qilish orqali investor moddiy aktivlarga nisbatan narx inflyatsiyasining darajasini baholaydi. Advanced Biomed Inc (ADVB) uchun bunday kutimlar saratonni erta tashxislash tizimlarining ishlab chiqilishi bilan asoslanadi. Yuqori malakali muhandislar jamoasi ko'pincha balans hisobotidagi raqamlardan yuqori bo'lgan intellektual qiymatni yaratadi.

Asosiy raqobatchilar

BeiGene Ltd (ONC) - Bozor kapitallashuvining balans qiymatiga nisbati|halozyme.com (HALO) - Bozor qiymatining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati RVMD|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati URGN (UroGen Pharma Corp)|BCAX - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati personalis.com PSNL|ERAS: Bozor kapitallashuvining balans qiymatiga nisbati|DCTH - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati YMAB|AURA (Aura Corp) - Bozor qiymatining balans qiymatiga koeffitsiyenti|CADL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati accuray.com (ARAY)|SELLAS Life Sciences (SLS) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati Actuate Therapeutics Inc. (ACTU)|Citius Oncology, Inc - Bozor kapitallashuvining balans qiymatiga nisbati|HURA - Kapitallashuvning sof aktivlarga nisbati|Protara Therapeutics - Kapitallashuvning sof aktivlarga nisbati|FATE: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati aadibio.com WHWK|TScan Therapeutics, Inc. (TCRX) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CSBR (Champions Oncology Inc)|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA|Bozor kapitallashuvining balans qiymatiga nisbati CVM|Bozor kapitallashuvining balans qiymatiga nisbati ostherapies.com (OSTX)|RADX - Bozor kapitallashuvining balans qiymatiga nisbati|ARTV - Kapitallashuvning balans qiymatiga nisbati|ANL - Kapitallashuvning sof aktivlarga nisbati|VERU - Bozor qiymatining balans qiymatiga nisbati|TPST: Bozor kapitallashuvining balans qiymatiga nisbati|XLO (Xilio Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati Renovaro Biosciences (RENB)|Kapitallashuvning balans qiymatiga nisbati Mural Bio|Bozor kapitallashuvining balans qiymatiga nisbati KAPA (Kairos Pharma Ltd)|Kapitallashuvning sof aktivlarga nisbati onkuretherapeutics.com (OKUR)|GDTC: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Curis Inc. CRIS|Apollomics Corp (APLM) - Bozor kapitallashuvining balans qiymatiga nisbati|Tharimmune Inc (THAR) - Kapitallashuvning balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Genprex, Inc GNPX|Calidi Biotherapeutics, Inc. (CLDI) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati Sunshine Biopharma|Bozor qiymatining balans qiymatiga nisbati Xenetic Bio|SLRX (Salarius Pharmaceuticals, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi PPBT (Purple Biotech Ltd)|AONC: Bozor qiymatining balans qiymatiga nisbati|BeiGene Ltd - Bozor qiymatining balans qiymatiga koeffitsiyenti|CKPT: Bozor qiymatining balans qiymatiga nisbati|ELEV - Kapitallashuvning sof aktivlarga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati ICAD|Ikena Oncology (IKNA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Bozor kapitallashuvining balans qiymatiga nisbati Notable Labs Inc. (NTBL)|Kapitallashuvning balans qiymatiga nisbati Viracta (VIRX)|MorphoSys AG (MOR) - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati nayabiosciences.com (NAYA)|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV